Shengyong Yang

14.9k citations
258 papers · 10.0k · 6 hit papers · h-index 46

Impact in

Papers in

    • Epigenetics and DNA Methylation 20
    • Histone Deacetylase Inhibitors Research 18
    • Cancer-related gene regulation 18
    • Protein Degradation and Inhibitors 16
    • Synthesis and biological activity 21

Shengyong Yang

254 papers receiving 9.9k citations

Shengyong Yang's Hit Papers

Artificial intelligence in drug development 2025 · 110 citations
1100+5+10Years since publication2505007501000

Peers

Shengyong Yang
Comparison fields: 5 of 186
  • Computational Theory and Mathematics 1.6k
  • Organic Chemistry 2.4k
  • Molecular Biology 5.6k
  • Cancer Research 950
  • Toxicology 186
Replace David B. Ascher with:
David B. Ascher Australia
Anton Simeonov United States
Mingyue Zheng China
Christopher P. Austin United States
Douglas E. V. Pires Australia
Kaixian Chen China
Antonio Lavecchia Italy
Xiaomin Luo China
Duxin Sun United States
Ruili Huang United States
Shengyong Yang relative to David B. Ascher Australia David B. Ascher's profile →
Citations per field
00.5×1.5×2.5×
David B. Ascher · 1×
Citations per year

Countries citing papers authored by Shengyong Yang

Since Specialization
Citations

This map shows the geographic impact of Shengyong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyong Yang more than expected).

Fields of papers citing papers by Shengyong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyong Yang. The network helps show where Shengyong Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Shengyong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shengyong Yang Line = papers co-authored together Shengyong Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 258 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Hit paper breakdown →
20211071
2
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Hit paper breakdown →
2019735
3
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Hit paper breakdown →
2019628
4
Pharmacophore modeling and applications in drug discovery: challenges and recent advances
Hit paper breakdown →
2010588
5
Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease
Hit paper breakdown →
2018446
6 2007216
7 2008126
8 2017123
9
Artificial intelligence in drug development
Hit paper breakdown →
2025110
10 2017108
11 200899
12 201998
13 201693
14 201190
15 201482
16 200978
17 200777
18 201776
19 200874
20 199272

About Shengyong Yang

Shengyong Yang is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Computational Theory and Mathematics and Materials Chemistry, having authored 258 papers that have together received 10.0k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (40 papers), Synthesis and biological activity (21 papers), Epigenetics and DNA Methylation (20 papers), Histone Deacetylase Inhibitors Research (18 papers), Cancer-related gene regulation (18 papers), Protein Degradation and Inhibitors (16 papers), Cancer-related Molecular Pathways (14 papers) and Cancer Mechanisms and Therapy (12 papers). The work is most often cited by research in Computational Theory and Mathematics (1.6k citations), Organic Chemistry (2.4k citations), Molecular Biology (5.6k citations), Cancer Research (950 citations) and Toxicology (186 citations). Shengyong Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Linli Li, Yuquan Wei, Yifei Wang, Gisbert Schneider, Xin Yang, Ryan Byrne, Lei Zhong, Chenyu Tian, Wenjing Wang and Tianqi Wang. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Organometallics and Signal Transduction and Targeted Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact